RE:HUGE NEWS : $4 MILLION IN FUNDING FROM NRCThe timeline for Arch's use of 4M in government funding is one that throws everything at the wall everywhere all at once. The probability of Arch ever getting to an FDA approval remains a very tall task at best. Better than 99% of any drug tied to any COVID-19 clinical trial - for any clinical reason - that's registered anywhere around the world - has secured zero (0) commercialization approvals from any regulatory agency including the FDA ("The Gold Standard"). Arch's latest funding news release is merely a carbon copy of their last government funding news release. Meanwhile, time waits for no one as the world moves towards the next global pandemic.
Godspeed